Use of Intrapleural Alteplase in the Treatment of Parapneumonic Effusion in Children: A Report of a 10-year Experience
Lower alteplase doses (≤2 mg) were effective for most children with PPE. Alteplase combined with primary VATS might be associated with better outcomes.
Authors
- Taylor Morrisette (ORCID: https://orcid.org/0000-0002-1094-043X)
- Yusuf M. Garwan (ORCID: https://orcid.org/0000-0001-6075-235X)
- Muath A. Alsalloum (ORCID: https://orcid.org/0000-0002-9424-1416)
- A. Jill Thompson (ORCID: https://orcid.org/0000-0001-6376-0857)
- Katherine Chessman
Institutions
- Medical University of South Carolina (US)
- Imam Abdulrahman Bin Faisal University (SA)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2025-08-01
- DOI
- https://doi.org/10.5863/jppt-24-00057
- Primary Topic
- Pleural and Pulmonary Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00